AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site
By: Colorado BioScience Association Date: 01/22/2021
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, Colorado site. Effective February 1, 2021, David Stewart will join the Boulder team as the General Manager/Site Head.
Find out more in the AGC Biologics press release.
Categories: Ecosystem News